Lisocabtagene maraleucel delivers sustained survival benefits and long-term disease control in relapsed or refractory LBCL.

Findings from a recent phase 3b/4 study of upadacitinib support a treat-to-target strategy for dose escalation or reduction ...

SGLT2 inhibitors and GLP-1 receptor agonists lower cardiovascular risk in type 2 diabetes, but a recent review suggests that ...

Same-day discharge after complex gynecologic oncology surgery is safe and feasible, with success tied to age, BMI, surgery ...

Optical coherence tomography is beneficial for measuring visual changes and the impact of comorbidities in MS, NMOSD, and ...

Associations between hormone therapy and young-onset breast cancer (diagnosed at younger than 55 years) vary, according to a ...

Only 34 percent of patients with erythema migrans >5 cm are positive for Lyme disease by a standard two-tier testing (STTT) ...

Almost 15 percent of U.S. adults aged 50 to 80 years are taking aspirin for primary cardiovascular disease prevention, ...

A recent study shows that cancer survivors’ out-of-pocket costs for necessary medical equipment are sometimes so high that ...

For younger acute myocardial infarction (AMI) survivors, living in marginalized neighborhoods is associated with adverse ...

The U.S. Food and Drug Administration has published more than 200 complete response letters, or decision letters, sent as ...

Stratifying body mass index (BMI) categories by waist circumference (WC) thresholds improves mortality risk prediction in ...